Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: ATRA) | Delayed: 9.40 -0.08 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.48 | 52 Week High | $40.80 | |||
| Open | $9.59 | 52 Week Low | $12.45 | |||
| Day High | $9.63 | P/E | N/A | |||
| Day Low | $8.95 | EPS | $0.00 | |||
| Volume | 39,318 | |||||
